Swiss Tech Startups Attract €3.3 Billion Amid Focus on Deeptech and AI

Switzerland’s technology startup ecosystem remained resilient and strongly specialised in 2025, attracting €3.3 billion in funding across several hundred investment rounds. This performance reinforces Switzerland’s reputation as one of Europe’s most capital-efficient innovation hubs and highlights its role as a centre for science-driven and advanced technology sectors.

Investment activity in 2025 was primarily concentrated in deep technology, healthcare, biotechnology, industrial AI, and climate-focused solutions. Healthcare and biotechnology represented the largest share of activity, reflecting ongoing investor interest in the intersection of life sciences and automation. In addition, climate and energy technologies drew significant capital, mirroring a broader European shift towards decarbonisation and the strengthening of energy infrastructure.

A strong early-stage pipeline, together with close ties between startups, research institutions, and international investors, continues to characterise the ecosystem. Swiss startups are increasingly collaborating with academic centres and attracting global capital to develop and scale high-impact technologies. As global demand grows for deeptech, healthcare, and climate solutions, Switzerland remains positioned as a leading developer of next-generation innovation.

Among the top fundraising companies in 2025 were:

• Energy Vault ($378M): Specialising in energy storage, the firm deploys gravity-based systems and hybrid battery/hydrogen solutions to help utilities manage renewable energy assets.

• Teylor (€150M): A fintech company digitising and automating SME lending, enabling faster business financing through digital platforms.

• Climeworks ($162M): A climate technology business developing direct air capture (DAC) systems to remove CO₂ from the atmosphere for permanent underground storage.

• Distalmotion ($150M): Medtech innovator with a robotic surgery system (DEXTER®) aiming to make minimally invasive procedures more accessible.

• Auterion ($130M): Provider of AI-powered drone operating systems, building software stacks for coordinated unmanned vehicle fleets across enterprise and defence applications.

• GlycoEra ($130M): Biotechnology firm creating precision therapies for autoimmune diseases by targeting disease-causing proteins with glycoengineering and protein-degradation technologies.

• Oculis (€106.2M): Developer of topical eye treatments for ophthalmic and neuro-ophthalmic diseases using advanced drug delivery.

• CeQur ($120M): Innovation in diabetes management through wearable insulin delivery systems designed to simplify daily therapy.

• Ecorobotix ($105M): Agritech startup providing AI-powered, ultra-precise spraying systems for sustainable crop protection.

• Neural Concept ($100M): AI software provider embedding deep learning and generative AI into engineering workflows to accelerate product design and simulation.

These investments demonstrate the breadth of Swiss innovation, from industrial AI and fintech to advanced medical robotics. As attention grows on climate technology, automation, and precision medicine, Switzerland's scientific foundation, access to capital, and collaborative culture are likely to drive further advances in the European and global tech landscape.

Source: tech.eu